Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
CALL
Boston Scientific
BSX
$74.9B
| $3.38M | ﹤0.01% |
31,500
-47,500
| -60% | -$4.81M |
|
2402
CALL
GitLab
GTLB
$7.32B
| $3.38M | ﹤0.01% |
75,000
-169,600
| -69% | -$7.76M |
|
2403
LeMaitre Vascular
LMAT
$1.87B
| $3.38M | ﹤0.01% |
40,726
+12,177
| +43% | +$1.02M |
|
2404
Autoliv
ALV
$8.89B
| $3.38M | ﹤0.01% |
30,215
-12,074
| -29% | -$1.18M |
|
|
NBIS
2405
PUT
Nebius Group N.V.
NBIS
$69.3B
| $3.38M | ﹤0.01% |
61,100
-474,000
| -89% | -$16.3M |
|
|
KKR.PRD
2406
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.59B
| $3.38M | ﹤0.01% |
63,040
-23,380
| -27% | -$1.15M |
|
2407
Leonardo DRS
DRS
$11.9B
| $3.38M | ﹤0.01% |
72,649
-169,686
| -70% | -$6.81M |
|
2408
United Natural Foods
UNFI
$2.94B
| $3.38M | ﹤0.01% |
144,808
+55,786
| +63% | +$1.45M |
|
2409
American Eagle Outfitters
AEO
$2.73B
| $3.37M | ﹤0.01% |
350,715
+97,627
| +39% | +$1.05M |
|
2410
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $3.37M | ﹤0.01% |
56,361
+20,450
| +57% | +$1.17M |
|
2411
National Vision
EYE
$1.51B
| $3.36M | ﹤0.01% |
146,080
+46,894
| +47% | +$800K |
|
2412
Northwest Natural Holdings
NWN
$2.14B
| $3.36M | ﹤0.01% |
84,612
+27,138
| +47% | +$1.13M |
|
2413
Diamondrock Hospitality Co
DRH
$2.51B
| $3.35M | ﹤0.01% |
437,927
+167,315
| +62% | +$1.25M |
|
2414
Immunocore
IMCR
$1.74B
| $3.35M | ﹤0.01% |
106,862
-228
| -0.2% | -$7.08K |
|
2415
Phreesia
PHR
$780M
| $3.35M | ﹤0.01% |
117,751
-68,596
| -37% | -$1.74M |
|
|
VNET
2416
VNET Group
VNET
$2.12B
| $3.35M | ﹤0.01% |
485,481
-116,818
| -19% | -$700K |
|
2417
CALL
Valaris
VAL
$5.91B
| $3.34M | ﹤0.01% |
79,400
| – | – |
|
|
2418
PUT
Valaris
VAL
$5.91B
| $3.34M | ﹤0.01% |
79,400
| – | – |
|
2419
Minerals Technologies
MTX
$2.26B
| $3.34M | ﹤0.01% |
60,597
+18,849
| +45% | +$1.06M |
|
2420
Enovix
ENVX
$966M
| $3.33M | ﹤0.01% |
367,993
+125,242
| +52% | +$817K |
|
2421
Amneal Pharmaceuticals
AMRX
$6.02B
| $3.33M | ﹤0.01% |
411,531
+124,161
| +43% | +$936K |
|
2422
Sunstone Hotel Investors
SHO
$2.02B
| $3.33M | ﹤0.01% |
383,493
-224,440
| -37% | -$1.93M |
|
2423
Sylvamo
SLVM
$1.55B
| $3.33M | ﹤0.01% |
66,415
+13,834
| +26% | +$779K |
|
|
2424
PUT
GitLab
GTLB
$7.32B
| $3.32M | ﹤0.01% |
73,700
+28,700
| +64% | +$1.31M |
|
2425
CALL
Array Technologies
ARRY
$796M
| $3.32M | ﹤0.01% |
+562,500
| New | +$3.42M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.